Grifols SA - ADR - Level III

NASDAQ:GRFS   3:59:45 PM EDT
15.23
-0.74 (-4.61%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.93B
Current PE5.55
Forward PE 11.62
2yr Forward PE 9.76
See more stats
Estimates Current Quarter
Revenue$1.58 Billion
Adjusted EPS$0.34
See more estimates
10-Day MA$15.93
50-Day MA$17.72
200-Day MA$18.10
See more pivots

Grifols SA Stock, NASDAQ:GRFS

Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Barcelona, Catalonia 08174
Phone: +34.93.571.22.00
Number of Employees: 24016

Description

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by Jos Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.